CL
AXSM icon

CSS LLC’s Axsome Therapeutics AXSM Stock Holding History

CSS LLC’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-37,100
Closed -$2.86M – 738
2022
Q4 		$2.86M Buy
37,100
+27,100
+271% +$1.62M 0.16% 128
2022
Q3 		$446K Sell
10,000
-19,900
-67% -$994K 0.02% 549
2022
Q2 		$1.15M Buy
+29,900
New +$946K 0.05% 397
2022
Q1 		– Sell
-26,500
Closed -$1M – 1167
2021
Q4 		$1M Buy
26,500
+2,400
+10% +$88.3K 0.04% 427
2021
Q3 		$795K Buy
+24,100
New +$939K 0.03% 486
2020
Q4 		– Sell
-500
Closed -$36K – 819
2020
Q3 		$36K Sell
500
-28,500
-98% -$2.22M ﹤0.01% 724
2020
Q2 		$2.39M Buy
29,000
+28,700
+9,567% +$2.21M 0.14% 155
2020
Q1 		$18K Sell
300
-133,100
-100% -$10.8M ﹤0.01% 563
2019
Q4 		$13.8M Buy
+133,400
New +$5.39M 0.76% 25

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CSS LLC's AXSM Position: Q1 2023 in Review

CSS LLC sold out of Axsome Therapeutics (AXSM) in Q1 2023, closing a stake of 10,613 shares — an estimated $819K sold.

CSS LLC first reported a position in AXSM in Q4 2019 and held it in 10 quarters. The position peaked at $7.19M in Q4 2019. 196 funds tracked by Wall St. Rank hold AXSM as of Q1 2023.

  • CSS LLC reported no remaining Axsome Therapeutics position as of Q1 2023 after selling out during the quarter.
  • CSS LLC sold 10,613 Axsome Therapeutics shares in Q1 2023, an estimated $819K.
  • CSS LLC first reported a position in Axsome Therapeutics in Q4 2019 and held it in 10 quarters.
  • CSS LLC's Axsome Therapeutics position peaked at $7.19M in Q4 2019.
  • 196 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2023.

Based on CSS LLC's 13F filing for Q1 2023, filed 15 May 2023.